tokens: Promoter activity was dose dependently inhibited by cotransfection with either ras or mos oncogenes , but oncogene inhibition was reversed and the overall activity increased when cells were treated with the MAP kinase kinase ( MKK ) inhibitor PD98059 .
folded_tokens: promoter activity be dose dependently inhibit by cotransfection with either ra or mo oncogene , but oncogene inhibition be reverse and the overall activity increase when cell be treat with the map kinase kinase ( mkk ) inhibitor pd98059 .